MiMedx Group Inc. | Mutual Funds
Mutual Funds that own MiMedx Group Inc.
SPDR S&P Biotech ETF
6,421,577
5.78%
16,521
0.57%
09/06/2018
iShares Core S&P Small Cap ETF
5,612,808
5.05%
1,590
0.06%
09/06/2018
Vanguard Explorer Fund
2,918,686
2.63%
0
0.09%
06/30/2018
Vanguard Total Stock Market Index Fund
2,657,736
2.39%
0
0%
07/31/2018
iShares Russell 2000 ETF
2,127,265
1.92%
-1,137
0.02%
09/06/2018
ClearBridge Small Cap Growth Fund
1,992,356
1.79%
0
0.28%
01/31/2018
iShares S&P Small Cap 600 Growth ETF
1,752,042
1.58%
2,514
0.13%
09/06/2018
Vanguard Extended Market Index Fund
1,352,054
1.22%
-485
0.01%
07/31/2018
Vanguard Small Cap Index Fund
1,239,806
1.12%
1,566
0.01%
07/31/2018
Government Pension Fund - Global (The)
1,209,183
1.09%
1,209,183
0%
12/31/2017
| Address |
1775 West Oak Commons Court NE
Marietta Georgia 30062
United States
|
|
Employees
|
- |
| Website |
http://www.mimedx.com |
| Updated |
07/08/2019 |
| MiMedx Group, Inc. is a biopharmaceutical company. It engages in the design, manufacture, and marketing of regenerative biomaterials products and tissue processing services for the wound care, surgical, sports medicine, ophthalmic and dental market categories. The company's allograft product families include dHACM family with AmnioFix, EpiFix and EpiBurn brands; Amniotic Fluid family with OrthoFlo brand; Umbilical family with EpiCord and AmnioCord brands; Placental Collagen family with CollaFix and AmnioFill brands; Bone family with Physio brand; and Skin family with AlloBurn brand. |
